8-K
SS Innovations International, Inc. (SSII)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of The SecuritiesExchange Act of 1934
Date of report (Date of earliest event reported): April 7, 2026
SS INNOVATIONS INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
| Florida | 001-42615 | 47-3478854 |
|---|---|---|
| (State or Other Jurisdiction<br><br>of Incorporation) | (Commission File Number) | (IRS Employer<br><br>Identification No.) |
| 405, 3rd Floor, iLabs Info Technology Centre<br><br> <br>Udyog Vihar, Phase III<br><br> <br>Gurugram, Haryana India | 122016 | |
| --- | --- | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code:
+91 73375 53469
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each Class | Trading Symbol | Name of each exchange on which registered |
|---|---|---|
| Common Stock | SSII | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
As used in this Current Report on Form 8-K (this “CurrentReport”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.
Item 8.01 Other Events.
On April 7, 2026, SSi issued a press release announcing it is hosting the Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026), being held in New Delhi, India, from April 9 to 11, 2026.
A copy of the press release is included as Exhibit99.1to this Current Report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description |
|---|---|
| 99.1 | Press Release, dated April 7, 2026 |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: April 7, 2026 | SS INNOVATIONS INTERNATIONAL, INC. | |
|---|---|---|
| By: | /s/ Sudhir Srivastava | |
| Sudhir Srivastava, M.D. | ||
| Chairman and Chief Executive Officer |
2
Exhibit 99.1
SS Innovations to Host SMRSC 2026 in New Delhi,India from April 9-11, 2026
Conference to Unite Global Leaders at the Forefrontof Surgical Robotic Innovation
FortLauderdale, FL – April 7, 2026 – SS Innovations International, Inc. (the “Company” or “SSInnovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company is hosting the Global Multi-Specialty Robotic Surgery Conference (“SMRSC 2026”) in New Delhi, India from April 9-11, 2026.
In this third installment of the event, SMRSC 2026 will bring together distinguished surgeons, global thought leaders and prominent innovators to discuss and shape the future of robotic and minimally invasive surgery. Attendance at SMRSC 2026 is expected to surpass that of last year’s conference, which drew more than 1,400 attendees and 600 virtual participants from 17 nations.
Among this year’s conference highlights:
| ● | Live Telesurgeries – During SMRSC 2026, more than 20 live telesurgeries will be performed<br> with the SSi Mantra surgical robotic system, spanning multiple specialties and led by top<br> experts in robotic surgery. These live demonstrations will provide a platform to explore<br> critical aspects of telesurgery, including connectivity, latency management, cybersecurity,<br> and clinical protocols, further strengthening the foundation for widespread adoption. |
|---|---|
| ● | SSi MantrAsana Tele Surgeon Console – Among the live telesurgeries to be conducted,<br> several procedures will utilize the SSi MantrAsana Tele Surgeon Console, a compact self-contained<br> chair-based version of the larger SSi Mantra surgeon command center that enables portability,<br> requires less space, and facilitates the performance of telesurgeries from a wide range of<br> settings including physician offices. |
| --- | --- |
| ● | SSi Vimana Aero Drone System (the “SSi Vimana Aero”) – One of the innovations<br> to be showcased at SMRSC 2026 is the SSi Vimana Aero, a drone deployed trauma surgery system<br> currently under development. The SSi Vimana Aero is designed to bring expert robotic surgical<br> care directly to wounded soldiers in active battle zones, bridging the critical time gap<br> between initial point of injury and eventual medical evacuation from the frontlines. Deployed<br> via a heavy-lift autonomous drone, the SSi Vimana Aero lands in proximity to the casualty<br> and deploys two miniature robotic arms with seven degrees of freedom. A trauma surgeon remotely<br> operates the SSi Vimana Aero, which is equipped with 5mm surgical instruments, through an<br> SSi Mantra surgeon command center. The SSi Vimana Aero platform is designed to address hemorrhaging,<br> wound repair, chest decompression, shrapnel extraction, and field suturing, among other procedures,<br> to help stabilize patients until evacuation teams arrive. |
| --- | --- |
| ● | Project Operion – An interactive window into the future of surgical robotic technologies,<br> Project Operion will touch on: enhanced access and training beyond hospital walls; critical<br> environments involving mobile high-tech surgical infrastructure; and telesurgery integration<br> combining real-time connectivity with robotic precision to deliver long-distance healthcare.<br> This immersive display of the “Operating Room of the Future,” showcases the benefits<br> of a mobile operating room platform that is entirely on wheels. |
| --- | --- |
| ● | MantraM Mobile Robotic Telesurgery Unit (the “MantraM bus”) – The MantraM bus,<br> which is designed to bring specialized surgical robotic care to the patient and training<br> to the medical professional regardless of location, will be on display at SMRSC 2026. The<br> MantraM bus provides an opportunity to overcome traditional cost and distance hurdles, enabling<br> delivery of world-class surgical care to underserved patient communities. |
| --- | --- |
| ● | Multispecialty and Cardiac-Focused Sessions – Live surgical demonstrations and panel discussions<br> at this year’s event will span specialties, including urology, thoracic, gastroenterology,<br> head & neck, gynecology, colorectal, general and pediatric, among others, with separate<br> cardiac-focused breakout sessions. |
| --- | --- |
| ● | Distinguished Guests and Presenters – Renowned surgeons, medical professionals and educators<br> from around the globe will be attending SMRSC 2026, including the Company’s Vice-Chairman,<br> Dr. Fred Moll, who has been widely recognized as the “Father of Robotic Surgery.”<br> Other guests of honor include Sri Madhusudan Sai, a global humanitarian and founder of a<br> worldwide free healthcare mission; Dr. Naresh Treahan, Managing Director, Medanta; Dr. Mylswamy<br> Annadurai, Former Director, ISRO Satellite Center; and Dr. Ashutosh Tewari, Chairman, Department<br> of Urology at the Icahn School of Medicine at Mount Sinai. |
| --- | --- |
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “We are thrilled to host SMRSC 2026 this week in New Delhi, where global experts in surgical robotic care will convene to discuss innovation and the future of our field. From live telesurgeries and robotic surgeries to demonstrations of exciting new technologies, this year’s event will be our largest and will continue to elevate the theme of decentralizing and democratizing access to surgical robotic care.”
About SMRSC 2026
SMRSC 2026 is a global multi-specialty robotic surgery conference bringing together surgeons, innovators, educators, and healthcare leaders. The event will showcase live procedures, innovation, panel discussions, presentations by distinguished guests, and professional collaboration to shape the future of robotic surgery.
| ● | Dates:<br> April 9–11, 2026 |
|---|---|
| ● | Location:<br> New Delhi, India |
| --- | --- |
| ● | Venue:<br> West Plaza, Bharat Mandapam |
| --- | --- |
To learn more, please visit: https://ssinnovations.com/SMRSC_2026/about/.
To register for the conference, please visit: https://ssinnovations.com/SMRSC_2026/register/.
2
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.
About the SSi Mantra
The SSi Mantra surgical robotic system is a user-friendly, modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana Tele Surgeon Console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that provides equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures.
Forward Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Investor Contact:
The Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
kahl@theequitygroup.com
Devin Sullivan, Managing Director
T: (212) 836-9608
dsullivan@theequitygroup.com
Media Contact:
RooneyPartners LLC
Kate Barrette
T: (212) 223-0561
kbarrette@rooneypartners.com
3